Poor sleep linked to rising cancer rates in adults under 50

According to The Guardian, two large new studies suggest that poor sleep patterns may be contributing to rising cancer diagnoses among adults under 50. The findings join a growing body of work trying to make sense of the global rise in early-onset cancer rates.
As The Guardian reports, worldwide early-onset cancer cases under 50 rose by about 80 per cent across three decades, climbing from 1.82 million in 1990 to 3.26 million in 2019. Cancer-related deaths among people aged 40 and under rose by 27 per cent over the same period.
The first of the studies examined sleep data on more than 1.2 million volunteers aged 24 to 49 in a US-based biobank. People sleeping less than six hours showed a higher risk of certain cancer types compared with those sleeping seven to eight hours. The results were presented with expert commentary in The Guardian's coverage.
The second study was conducted in Europe and involved long-term follow-up; people with irregular sleep-wake cycles showed a trend toward increased breast, colon and liver cancer cases. The Guardian emphasises that the authors do not claim direct causation and that observational data shows association only.
Experts said that sleep plays a critical role in immune function, hormonal balance and cell repair processes. The lead authors wrote that sleep loss may disrupt circadian rhythm, affecting inflammation and cell renewal, and that 'further work is required to investigate the possible mechanisms'.
The Guardian quoted Dr Naomi Allen, a senior representative of Cancer Research UK. Allen said the studies were 'observational and do not assert causation', and stressed the importance of assessing sleep alongside other lifestyle factors (diet, physical activity, alcohol consumption) as part of the whole picture.
Another notable finding in the studies was that similar trend patterns were observed among shift workers. The Guardian recalls that this does not conflict with the World Health Organization's 2007 classification of shift work as a 'probable carcinogen' (Group 2A).
Clinical experts said that sleep is not by itself a cause of cancer, but should be considered as a modifiable lifestyle factor. Regular sleep hours, reduced screen exposure and well-organised sleep environments were cited as the basic recommendations.
The Guardian also carried commentary from Dr Sophie Hardefeldt of Imperial College London's epidemiology department. Hardefeldt said the studies' strength is their large sample size, but they need to be tested again across different cultures and income groups. 'A single study cannot shape cancer policy,' she said.
Experts emphasised that this article should not be read as medical advice, and that specialist clinical consultation should be sought for personal cancer-risk assessment. This piece is limited to summarising the findings and expert commentary reported by The Guardian; for individual health planning on sleep and cancer, a qualified clinician should be consulted.